SEP-1 对急诊科广谱联合抗生素使用的影响
该回顾性研究纳入 400 例在急诊因尿路感染或皮肤软组织感染接受万古霉素联合抗假单胞菌 β-内酰胺类治疗的成人患者,比较 SEP-1 实施前后广谱联合治疗(BSCT)的适当性。实施后 BSCT 适当使用比例下降 12%(54% vs 42%,p=0.028),疑似尿路感染亚组下降 25%(40% vs 15%,p=0.005)。两组 door to first antibiotic administration 中位时间无显著差异(63 min vs 61 min,p=0.091)。作者认为 SEP-1 强制措施可能对急诊抗菌药物使用产生负面影响。
要点
- SEP-1 实施后急诊 BSCT 适当使用率从 54% 降至 42%(下降 12%,p=0.028)。
- 疑似尿路感染亚组 BSCT 适当率从 40% 降至 15%(下降 25%,p=0.005)。
- door to first antibiotic administration 中位时间两组无显著差异(63 min vs 61 min,p=0.091)。
- 作者认为 SEP-1 强制措施与 BSCT 不必要使用增加相关,且未改善给药时间。
适用人群与场景
- 在急诊科因尿路感染或皮肤软组织感染接受万古霉素联合抗假单胞菌 β-内酰胺类治疗的成人患者。
研究设计与关键结果
- 研究类型为 IRB 批准的回顾性评价,共纳入 400 例成人患者。
- 主要结局为基于临床标准判断 BSCT 是否适当;SEP-1 实施后适当使用比例下降 12%(SEP-1 前组 54% vs SEP-1 后组 42%,p=0.028)。
- 疑似尿路感染亚组 BSCT 适当使用率下降 25%(SEP-1 前组 40% vs SEP-1 后组 15%,p=0.005)。
- door to first antibiotic administration 中位时间两组无显著差异(SEP-1 前组 63 min vs SEP-1 后组 61 min,p=0.091)。
- 次要结局还包括 door to antibiotic order time、入院时继续 BSCT 的患者比例、BSCT 持续时间及院内死亡率,摘要未报告具体结果。
证据类型、等级与局限
- 证据类型:回顾性评价(IRB 批准)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为 SEP-1 强制措施可能对急诊抗菌药物使用产生负面影响,表现为 BSCT 不必要使用增加。
- 作者结论提示 SEP-1 实施与 BSCT 适当使用率下降相关,且未观察到给药时间改善。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The SEP-1 measures have tied financial reimbursement to the treatment of patients with severe sepsis and septic shock. The purpose of this study was to assess the impact of a SEP-1 initiative on the utilization of broad-spectrum combination therapy (BSCT) in the emergency department (ED).
METHODS: This was an IRB-approved, retrospective evaluation of adult patients who received vancomycin plus an antipseudomonal beta-lactam for a urinary tract infection (UTI) or skin or soft tissue infection (SSTI) in the ED. The primary outcome was the proportion of patients in which use of BSCT was considered appropriate based on clinical criteria. Secondary outcomes included door to antibiotic order time, door to administration time, proportion of patients continued on BSCT upon admission, duration of BSCT, and in-hospital mortality.
RESULTS: A total of 400 patients were included in the analysis. Following SEP-1 implementation, appropriate use of BSCT decreased by 12%, with 54% of patients in the pre-SEP-1 group meeting clinical criteria compared to 42% in the post-SEP-1 group (p = 0.028). In the subgroup of patients with a suspected UTI the appropriate use of BSCT declined by 25% (40% vs 15%, p = 0.005). The median door to first antibiotic administration time was not significantly different between groups (63 min vs 61 min, p = 0.091).
CONCLUSIONS: The implementation of the SEP-1 mandated measures was associated with an increase in the unnecessary use of BSCT. Additionally, no difference was seen in time to antibiotic administration. The results of this study demonstrate the negative impact that the SEP-1 mandate may have on antimicrobial utilization within the ED.
参考来源
- Miller J, Hall B, Wilson K, et al. Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department. Am J Emerg Med. 2020. PMID: 31932126. doi:10.1016/j.ajem.2019.12.045
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。